ABEO- Abeona Therapeutics Inc.
Abeona Therapeutics Inc. (ABEO) has 7 insiders with recent SEC Form 4 filings, including 3 buys and 7 sells. ABEO is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.31M | $9.01M | -67,971 | |
| CFO | 493.6K | $3.41M | -24,880 | |
| VP | 428.0K | $2.95M | -12,050 | |
| Other | 290.6K | $2.01M | -12,606 | |
| Dir | 48.8K | $336.4K | - |
Activity
Buys and sells only
Transactions
10 filings · page 6
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 25, 2023 | Alvino Mark53 | Director | Sell | 887 | $3.25 | $2,882.75 | -4.8% | +10.4% | -2.8% | |
| Mar 20, 2023 | Amoroso Michael70 | Director | Sell | 268 | $2.33 | $624.44 | -0.5% | +97.8% | +229.1% | |
| Mar 3, 2023 | Amoroso Michael70 | Director | Sell | 1,002 | $2.38 | $2,384.76 | -1.7% | +20.9% | +208.7% | |
| Dec 9, 2022 | O'Malley Brendan M.85 | SVP, General Counsel | Buy | 5,869 | $3.13 | $18,369.97 | +6.7% | -8.3% | +53.2% | |
| Nov 18, 2022 | O'Malley Brendan M.85 | SVP, General Counsel | Buy | 7,500 | $3.99 | $29,925.00 | +9.3% | -42.1% | +3.7% | |
| Nov 18, 2022 | Vazzano Joseph Walter75 | Chief Financial Officer | Buy | 2,500 | $4.00 | $10,000.00 | +2.7% | -42.1% | +3.7% | |
| Jun 15, 2022 | Alvino Mark53 | Director | Sell | 20,000 | $0.15 | $3,098.00 | -42.4% | -4.8% | +11.1% | |
| Jun 6, 2022 | Alvino Mark53 | Director | Sell | 35,000 | $0.16 | $5,463.50 | -42.6% | -5.4% | +1.5% | |
| Dec 6, 2021 | O'Malley Brendan M.85 | SVP, General Counsel | Sell | 8,880 | $0.57 | $5,034.96 | -4.2% | -52.8% | -76.1% | |
| Nov 5, 2021 | O'Malley Brendan M.85 | SVP, General Counsel | Sell | 8,880 | $0.89 | $7,894.32 | -4.0% | -72.7% | -82.9% |